From NDTV
Center-Right Owned by Adani Group (AMG Media)Mankind Pharma Q2 Review: Export Momentum Continues; Systematix Maintains 'Hold'; Check Target Price
RSS excerpt
Mankind Pharma's consumer healthcare remains a key monitorable, with high-single-digit growth expected in FY27 and recovery anticipated in FY28, adds the brokerage.